CA2378285A1 - Vaccines for the treatment of autoimmune disease - Google Patents

Vaccines for the treatment of autoimmune disease Download PDF

Info

Publication number
CA2378285A1
CA2378285A1 CA002378285A CA2378285A CA2378285A1 CA 2378285 A1 CA2378285 A1 CA 2378285A1 CA 002378285 A CA002378285 A CA 002378285A CA 2378285 A CA2378285 A CA 2378285A CA 2378285 A1 CA2378285 A1 CA 2378285A1
Authority
CA
Canada
Prior art keywords
mice
vac
disease
ifa
pvac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002378285A
Other languages
English (en)
French (fr)
Inventor
Nanette Solvason
Simonetta Mocci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2378285A1 publication Critical patent/CA2378285A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
CA002378285A 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease Abandoned CA2378285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14762699P 1999-08-06 1999-08-06
US60/147,626 1999-08-06
PCT/US2000/021644 WO2001010221A1 (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
CA2378285A1 true CA2378285A1 (en) 2001-02-15

Family

ID=22522280

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002378285A Abandoned CA2378285A1 (en) 1999-08-06 2000-08-07 Vaccines for the treatment of autoimmune disease

Country Status (5)

Country Link
EP (1) EP1206190A1 (ja)
JP (1) JP2003510335A (ja)
AU (1) AU6896300A (ja)
CA (1) CA2378285A1 (ja)
WO (1) WO2001010221A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2305086T3 (es) * 2000-05-19 2008-11-01 Corixa Corporation Tratamiento profilactico y terapeutico de enfermedades alergicas, autoinmunes e infecciosas con compuestos con base de monosacaridos.
US20030139356A1 (en) 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030104012A1 (en) * 2001-05-11 2003-06-05 Corixa Corporation Vaccines for the treatment of autoimmune disease
US11077179B2 (en) * 2017-08-10 2021-08-03 Epicgenetics, Inc. Method for treating fibromyalgia and chronic fatigue syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
US5268170A (en) * 1986-09-09 1993-12-07 Yeda Research And Development Co., Ltd. Methods of treatment and diagnosis of autoimmune diseases, especially arthritic conditions
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis

Also Published As

Publication number Publication date
EP1206190A1 (en) 2002-05-22
WO2001010221A1 (en) 2001-02-15
JP2003510335A (ja) 2003-03-18
AU6896300A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
US10286053B2 (en) Compositions and methods
DE60132474T2 (de) Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung
US10441645B2 (en) MSLN targeting DNA vaccine for cancer immunotherapy
CA1333152C (en) Vaccine containing tumor antigens and adjuvants
JP7339942B2 (ja) サポニンを含むリポソーム製剤および使用方法
KR20140053887A (ko) 면역 반응을 증진시키는 조성물 및 방법
Ozeki et al. In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6, 6'-dimycolate)
TW201544120A (zh) 合成的葡萄吡喃糖基脂質佐劑
HUE028452T2 (en) Mycobacterium antigenic preparations
JP2001524951A (ja) 炎症性腸疾患を治療するための方法および組成物
US20160279213A1 (en) Survivin-Directed Cancer Vaccine Therapy
KR101819688B1 (ko) 변형된 면역-조절 입자
EP2734229B1 (en) Methods and copositions for vaccinating against staphylococcus aureus
EA024826B1 (ru) Способ лечения латентного туберкулеза
CN102164612A (zh) 新型组合物和方法
US8425913B2 (en) Immunogenic agents against Burkholderia pseudomallei and/or Burkholderia mallei, comprising lipopolysaccharide, capsular polysaccharide and/or proteins from Burkholderia pseudomallei
CA2378285A1 (en) Vaccines for the treatment of autoimmune disease
US20020044951A1 (en) Isolated and purified nonpeptide antigens from mycobacterium tuberculosis
WO1999052547A9 (en) Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
US20030104012A1 (en) Vaccines for the treatment of autoimmune disease
GB2467215A (en) Burkholderia thailandensis LPS vaccine
EP2341928B1 (en) Mycobacterium tuberculosis vaccine
US20190008952A1 (en) Enhanced immune response in aquatic species
Baranski Treatment of dermal cysticercosis with praziquantel: a new cestocidal agent
WO2022236370A1 (en) Immunogenic composition

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20050808